References
- VosTFlaxmanADNaghaviMYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592163219623245607
- TassorelliCGrecoRWangDSandriniGNappiGProstaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin testEur J Pharmacol20065341–310310716507304
- FerrariLFLevineJDGreenPGMechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the ratNeuroscience201631712112926779834
- BorkumJMMigraine triggers and oxidative stress: a narrative review and synthesisHeadache2016561123526639834
- GeyikSAltunısıkENeyalAMTaysiSOxidative stress and DNA damage in patients with migraineJ Headache Pain2016171026883365
- CarrascoCNaziroǧluMRodríguezABParienteJANeuropathic pain: delving into the oxidative origin and the possible implication of transient receptor potential channelsFront Physiol201899529491840
- BulboacăABolboacăSSuciSProtective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in ratsIran J Basic Med Sci201619658559327482338
- BulboacăAEBolboacăSDStănescuICSfrângeuCABulboacăACPreemptive analgesic and antioxidant effect of curcumin for experimental migraineBiomed Res Int20172017475470129204441
- HewlingsSJKalmanDSCurcumin: a review of its’ effects on human healthFoods2017610 pii: E92
- ChiuSSLuiEMajeedMDifferential distribution of intravenous curcumin formulations in the rat brainAnticancer Res201131390791121498712
- ZhengZSunYLiuZZhangMLiCCaiHThe effect of curcumin and its nanoformulation on adjuvant-induced arthritis in ratsDrug Des Devel Ther2015949314942
- SoveydNAbdolahiMDjalaliMThe combined effects of ω-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patientsCNS Neurol Disord Drug Targets201816101120112629237386
- GeraMSharmaNGhoshMNanoformulations of curcumin: an emerging paradigm for improved remedial applicationOncotarget2017839666806669829029547
- GanesanPKoHMKimISChoiDKRecent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease modelsInt J Nanomedicine2015106757677226604750
- KowalskaMPrendeckiMKozubskiWLianeriMDorszewskaJMolecular factors in migraineOncotarget2016731507085071827191890
- TokuokaKTakayanagiRToyabeMWatanabeMKitagawaYYamadaYTheoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancyJ Headache Pain2015167126242873
- AggarwalMPuriVPuriSSerotonin and CGRP in migraineAnn Neurosci2012192889425205974
- BecerraLBishopJBarmettlerGTriptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areasJ Neurophysiol2016115120821726490291
- StoyanovaIILazarovNELocalization of nitric oxide synthase in rat trigeminal primary afferent neurons using NADPH-diaphorase histochemistryJ Mol Histol200536318719315900409
- BermanNEPuriVChandralaSSerotonin in trigeminal ganglia of female rodents: relevance to menstrual migraineHeadache20064681230124516942467
- MacintyrePDBhargavaBHoggKJGemmillJDHillisWSThe effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulationBr J Clin Pharmacol19923465415461337261
- EvansRWTepperSJShapiroRESun-EdelsteinCTietjenGEThe FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paperHeadache20105061089109920618823
- SesarmanATefasLSylvesterBAnti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin, on C26 murine colon cancer cellsPharmacol Rep201870233133929477042
- TefasLRSylvesterBTomutaIDevelopment of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approachDrug Des Devel Ther20171116051621
- SufkaKJStaszkoSMJohnsonAPDavisMEDavisRESmithermanTAClinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in ratsJ Headache Pain2016174027093871
- BatesEANikaiTBrennanKCSumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in miceCephalalgia201030217017819489890
- TjølsenABergeOGHunskaarSRoslandJHHoleKThe formalin test: an evaluation of the methodPain19925115171454405
- HunskaarSHoleKThe formalin test in mice: dissociation between inflammatory and non-inflammatory painPain19873011031143614974
- MohammadAAliNRezaBAliKEffect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to leadIndian J Pharmacol2010422788120711370
- YaglKAssay for blood plasma and serum peroxidesMethods Enzymol19841052831
- ParvuAEParvuMVlaseLMicleaPMotACSilaghi-DumitrescuRAnti-inflammatory effects of Allium schoenoprasum L. leavesJ Physiol Pharmacol201465230931524781739
- EllmanGLA colorimetric method for determining low concentrations of mercaptansArch Biochem Biophys195874244345013534673
- MerinoJJArceCNaddafABellver-LandeteVOset-GasqueMJGonzálezMPThe nitric oxide donor SNAP-induced amino acid neurotransmitter release in cortical neurons. Effects of blockers of voltage-dependent sodium and calcium channelsPLoS One201493e9070324598811
- Nagy-GróczGTarLBohárZThe modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the ratCephalalgia201636984986126512068
- SchwartzESLeeIChungKChungJMOxidative stress in the spinal cord is an important contributor in capsaicin-induced mechanical secondary hyperalgesia in micePain2008138351452418375065
- BindokasVPJordánJLeeCCMillerRJSuperoxide production in rat hippocampal neurons: selective imaging with hydroethidineJ Neurosci1996164132413368778284
- PethoGReehPWSensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptorsPhysiol Rev20129241699177523073630
- MjellemNLundAEidePKStørksonRTjølsenAThe role of 5-HT1A and 5-HT1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviourNeuroreport1992312106110641337283
- BellamyJBowenEJRussoAFDurhamPLNitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neuronsEur J Neurosci20062382057206616630053
- DaherJBde MeloMDTonussiCREvidence for a spinal serotonergic control of the peripheral inflammation in the ratLife Sci200576202349235915748628
- BlumenfeldAGenningsCCadyRPharmacological synergy: the next frontier on therapeutic advancement for migraineHeadache201252463664722221151
- SmithTRSunshineAStarkSRLittlefieldDESpruillSEAlexanderWJSumatriptan and naproxen sodium for the acute treatment of migraineHeadache200545898399116109111
- ZhaoSMaLCaoCYuQChenLLiuJCurcumin-loaded redox response of self-assembled micelles for enhanced antitumor and anti-inflammation efficacyInt J Nanomedicine2017122489250428408820
- MonroyALithgowGJAlavezSCurcumin and neurodegenerative diseasesBiofactors201339112213223303664
- CeyhanDKocmanAEYildirimEOzatikOAydinSKoseAComparison of the effects of curcumin, tramadol and surgical treatments on neuropathic pain induced by chronic constriction injury in ratTurk Neurosurg201828228829528481389
- KapoorSCurcumin and its emerging role in pain modulation and pain managementKorean J Pain201225320220322787555
- YeonKYKimSAKimYHCurcumin produces an antihyperalgesic effect via antagonism of TRPV1J Dent Res201089217017420040737
- SunDZhuangXXiangXA novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomesMol Ther20101891606161420571541
- YallapuMMNageshPKJaggiMChauhanSCTherapeutic applications of curcumin nanoformulationsAAPS J20151761341135626335307
- Di MartinoPCensiRGigliobiancoMRNano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseasesCurr Pharm Des201723131897190828025942
- SinghAKJiangYGuptaSYounusMRamzanMAnti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammationJ Med Food2013161089991124138167
- AgnihotriNMishraPCScavenging mechanism of curcumin toward the hydroxyl radical: a theoretical study of reactions producing ferulic acid and vanillinJ Phys Chem A201111549142211423222035040
- TharakanBHunterFASmytheWRChildsEWCurcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shockClin Exp Pharmacol Physiol201037993994420528978
- FujisawaSAtsumiTIshiharaMKadomaYCytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compoundsAnticancer Res2004242B56356915160995
- BiswasSKMcClureDJimenezLAMegsonILRahmanICurcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activityAntioxid Redox Signal200571–2324115650394
- XuYHuNJiangWYuanHFZhengDHCurcumin-carrying nanoparticles prevent ischemia-reperfusion injury in human renal cellsOncotarget2016752873908740127901497
- ChanMMAdapalaNSFongDCurcumin overcomes the inhibitory effect of nitric oxide on LeishmaniaParasitol Res2005961495615772867
- YuLYiJYeGEffects of curcumin on levels of nitric oxide synthase and AQP-4 in a rat model of hypoxia-ischemic brain damageBrain Res20121475889522902770
- BegumANJonesMRLimGPCurcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s diseaseJ Pharmacol Exp Ther2008326119620818417733
- SreejayanRaoMNNitric oxide scavenging by curcuminoidsJ Pharm Pharmacol19974911051079120760
- SiafakaPIÜstündağ OkurNKaravasEBikiarisDNSurface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and usesInt J Mol Sci2016179 pii: E1440
- YuHLiJShiKHuangQStructure of modified ε-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoidsFood Funct20112737338021894323
- MohajeriMSadeghizadehMNajafiFJavanMPolymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down-regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repairNeuropharmacology20159915616726211978
- ZhangZYJiangMFangJEnhanced therapeutic potential of nano-curcumin against subarachnoid hemorrhage-induced blood-brain barrier disruption through inhibition of inflammatory response and oxidative stressMol Neurobiol201754111426708209
- GrecoRFerrignoADemartiniCEvaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraineJ Headache Pain20151656026272684
- SongTTBiYHGaoYQSystemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxiaJ Neuroinflammation20161316326968975
- DosSantosMFHolanda-AfonsoRCLimaRLDaSilvaAFMoura-NetoVThe role of the blood–brain barrier in the development and treatment of migraine and other pain disordersFront Cell Neurosci2014830225339863
- AbdolahiMTafakhoriAToghaMThe synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patientsImmunogenetics201769637137828478481
- EserAHizliDHaltasHEffects of curcumin on ovarian ischemia-reperfusion injury in a rat modelBiomed Rep20153680781326623020
- EdwardsRLLuisPBVaruzzaPVThe anti-inflammatory activity of curcumin is mediated by its oxidative metabolitesJ Biol Chem2017292212432125229097552
- SandurSKIchikawaHPandeyMKRole of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)Free Radic Biol Med200743456858017640567
- FraAYoboueEDSitiaRCysteines as redox molecular switches and targets of diseaseFront Mol Neurosci20171016728634440
- MatabudulDPucajKBolgerGVcelarBMajeedMHelsonLTissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogsAnticancer Res201232104359436423060559
- FischerMCarliGRaboissonPReehPThe interphase of the formalin testPain2014155351152124291649
- Salinas-AbarcaABAvila-RojasSHBarragán-IglesiasPPineda- FariasJBGranados-SotoVFormalin injection produces long-lasting hypersensitivity with characteristics of neuropathic painEur J Pharmacol2017797839328095324
- PachenariNAziziHGhasemiEAzadiMSemnanianSExposure to opiates in male adolescent rats alters pain perception in the male offspringBehav Pharmacol2018292 and 3 – Special Issue25526029543652
- BirmannPTSousaFSSde OliveiraDH3-(4-Chlorophenylselanyl)-1-methyl-1H-indole, a new selenium compound elicits an antinociceptive and anti-inflammatory effect in miceEur J Pharmacol2018827717929535001